21 December, 2022
Christmas greeting from CLS - We wish you all a very Happy Holiday season and look forward to a tremendous 2023!
At CLS we can look back on an exciting year where we have made significant progress towards our vision that laser ablation will be introduced as standard treatment in focal therapy and as an alternative to traditional surgery and, in the longer term, as a complementary systemic treatment of metastasized cancer.
Read more
28 November, 2022
Clinical data from a Phase II trial using CLS TRANBERG products presented during RSNA 2022 Annual Meeting
The RSNA (Radiological Society of North America) annual meeting is ongoing in Chicago, the US. Yesterday, interim data from the ongoing study in Toronto using CLS´s TRANBERG products, was presented by the principal investigator MD Sangeet Ghai.
Read more
2 November, 2022
Interview with our CTO and VP Clinical Affairs – How CLS contributes to better treatment of Prostate Cancer
Our CTO Cristina Pantaleone and VP Medical Affairs Hoda Tawfik, explain how the TRANBERG® Thermal Therapy Systems have been designed for precise and safe focal therapy of soft tissue, such as the prostate gland, and what kind of research CLS is now supporting.
Read more